C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2004
11/25/2004	WO2004101790A1 A process for recovering polypeptides that unfold reversibly from a polypeptide repertoire
11/25/2004	WO2004101789A1 Cardiotonic polypeptides
11/25/2004	WO2004101788A2 Small interfering rna libraries and methods of synthesis and use
11/25/2004	WO2004101787A1 Inhibition of the expression of huntington gene
11/25/2004	WO2004101786A1 TRANSFORMING GROWTH FACTOR-β RESPONSE ELEMENT DECOYS AND METHODS BASED THEREON
11/25/2004	WO2004101785A1 Method of extracting target gene and particle having probe dna bound thereto
11/25/2004	WO2004101783A1 A method of operating a target dna sequence
11/25/2004	WO2004101777A1 A recombinant virus comprising an intact tumor-therapeutic antibody with human costant regions and the use thereof
11/25/2004	WO2004101766A2 Grp94-based compositions and methods of use thereof
11/25/2004	WO2004101757A2 Production of polyunsaturated fatty acids in oleaginous yeasts
11/25/2004	WO2004101755A2 Ref1 modified plants and plant seeds
11/25/2004	WO2004101754A2 Plan regulatory sequences for selective control of gene expression
11/25/2004	WO2004101753A2 Codon-optimized genes for the production of polyunsaturated fatty acids in oleaginous yeasts
11/25/2004	WO2004101751A2 A modified rubisco large subunit ∈n-methyltransferase useful for targeting molecules to the active-site vicinity of ribulose-1, 5-bisphosphate
11/25/2004	WO2004101748A2 A method of increasing yield in a plant and genes useful therefor
11/25/2004	WO2004101746A2 Production of carotenoids in microorganisms
11/25/2004	WO2004101744A2 Plants with increased levels of one or more amino acids
11/25/2004	WO2004101741A2 Transgenic plants with increased glycine-betaine
11/25/2004	WO2004101622A1 Human monoclonal antibody specific for lipopolysaccharides (lps) of serotype iats 06 of pseudomonas aeruginosa
11/25/2004	WO2004101616A1 LIVER X RECEPTOR α SPLICING MUTANT PROTEIN, GENE THEREOF AND UTILIZATION OF THE SAME
11/25/2004	WO2004101614A1 Promoter sequences from hevea brasiliensis hevein genes
11/25/2004	WO2004101613A1 Extracting and purifying enzymes
11/25/2004	WO2004100990A1 Apoptosis inducer for cancer cell
11/25/2004	WO2004100977A1 Inhibition of tumor cell proliferation by foxm1b inhibitors
11/25/2004	WO2004100877A2 Vaccine accelerator factor (vaf) for poultry
11/25/2004	WO2004090142A3 Plants having modified growth characteristics and method for making the same
11/25/2004	WO2004090125A3 Method for producing l-amino acid using bacteria having enhanced expression of the gene pcka
11/25/2004	WO2004090124A3 Sequences encoding s-hydroxynitril lyases and their use in methods for the production of cyanohydrins
11/25/2004	WO2004088307A3 Detection method for the expression of recombinant proteins on a cell surface and for the immobilization and purification of cells and proteins
11/25/2004	WO2004087965A3 Statistical analysis of regulatory factor binding sites of differentially expressed genes
11/25/2004	WO2004087901A3 Brain-localized protein kinases homologous to homeodomain-interacting protein kinases
11/25/2004	WO2004085619A3 Expression of desirable proteins in plant roots and cell cultures
11/25/2004	WO2004085468A3 Human p53 splice variant displaying differential transcriptional activity
11/25/2004	WO2004081225A3 Amplification and analysis of whole genome and whole transcriptome libraries generated by a dna polymerization process
11/25/2004	WO2004080395A3 Methods and compositions for cancer treatment
11/25/2004	WO2004078123A3 Early prostate cancer antigens (epca), polynucleotide sequences encoding them, and their use
11/25/2004	WO2004075831A3 Pharmacodynamic assay for inhibitors of 11-beta-hydroxysteroid dehydrogenase activity in animal tissues
11/25/2004	WO2004073646A3 Treatment of pain through expression of opioid receptors
11/25/2004	WO2004072247A3 Polymerase-based protocols for generating chimeric and combinatorial chimeric oligonucleotides
11/25/2004	WO2004071443A3 Methods and compositions for modulating stem cells
11/25/2004	WO2004070027A3 Method for modifying plant growth characteristics
11/25/2004	WO2004069204A3 Immunogenic acute phase protein-antigenic molecule complexes and fusion proteins
11/25/2004	WO2004067736A3 Custom-made meganuclease and use thereof
11/25/2004	WO2004067567A3 Anti-dengue virus antibodies, compositions, methods and uses
11/25/2004	WO2004065603A3 Methods for increasing neisseria protein expression
11/25/2004	WO2004065423A3 Recognition molecules for the treatment and detection of tumours
11/25/2004	WO2004063346A3 Lysozyme transgenic ungulates
11/25/2004	WO2004063223A3 Notch-like polypeptides
11/25/2004	WO2004048601A3 Modulation of b7h expression
11/25/2004	WO2004037294A3 New settings for recombinant adenoviral-based vaccines
11/25/2004	WO2004033625A3 Urocortin-deficient mice and uses thereof
11/25/2004	WO2004029084A3 Lipase inhibitors and uses thereof
11/25/2004	WO2004022722A3 Lentiviral vectors, related reagents, and methods of use thereof
11/25/2004	WO2004018635A3 Myxococcus xanthus bacteriophage mx9 transformation and integration system
11/25/2004	WO2004018624A3 Random transposon insertion in staphylococcus aureus and use thereof to identify essential genes
11/25/2004	WO2003092594A8 Adeno-associated viral vectors and methods for their production from hybrid adenovirus and for their use
11/25/2004	WO2003086280A3 Immunostimulatory g,u-containing oligoribonucleotides
11/25/2004	WO2003085094A3 Solid phase methods for polynucleotide production
11/25/2004	WO2003072805A3 Recombinase polymerase amplification
11/25/2004	WO2003070906A3 Cellular genes regulated by hiv-1 infection and methods of use thereof
11/25/2004	WO2003070197A3 RNA INTERFERENCE MEDIATED INHIBITION OF TGF-BETA AND TGF-BETA RECEPTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
11/25/2004	WO2003050260A3 Streptavidin expressed gene fusions and methods of use thereof
11/25/2004	WO2003025148A3 Novel nucleic acids and polypeptides
11/25/2004	WO2002086097A8 Methods for identifying the target of a compound which inhibits cellular proliferation
11/25/2004	US20040237147 Modulation of cytokinin activity in plants
11/25/2004	US20040237146 Floral transformation
11/25/2004	US20040237145 Control of gene expression
11/25/2004	US20040237144 Anther-specific taa1 genes encoding fatty acyl co-a reductases, and uses thereof
11/25/2004	US20040237143 Seed composition and method for reducing and preventing the release of genetically manipulated pollen
11/25/2004	US20040237142 Incorporating non-lethal negative selectable marker gene into the vector backbone of a Agrobacterium plasmid used to transform cells involved in hormone biosynthesis, degradation, signaling or metabolic interference; antibiotic/herbicide resistance
11/25/2004	US20040237141 Plant gene regeneration; hybrids; reducing glucosinolates
11/25/2004	US20040237139 Production of hydroxylated fatty acids in genetically modified plants
11/25/2004	US20040237138 Method of increasing yield in a plant and genes useful therefor
11/25/2004	US20040237137 Solanum bulbocastanum late blight resistance gene and use thereof
11/25/2004	US20040237136 Transforming, propagating and generating cucumber green mottle mosaic virus (CGMMV) resistant cucurbitaceae; disease resistant plants
11/25/2004	US20040237135 ZmAXIG1 polynucleotides and methods of use
11/25/2004	US20040237134 Wheat plants having increased resistance to imidazoline herbicides
11/25/2004	US20040237133 Method for transformation of mono-and di-cotyledonous plants using meristematic tissue and nodal callus from dicotyledonous plants
11/25/2004	US20040237132 Plant promoters
11/25/2004	US20040237131 Using vector transformation and homologous recombination to generate transgenic tomato; heterologus gene expression in chloroplast; plant bioreactors
11/25/2004	US20040237128 Transgenic non-human animal having a disruption of at least one allele to the ceacam 1 gene and method of making same
11/25/2004	US20040237127 Composition and methods for the therapeutic use of an atonal-associated sequence for deafness, osteoarthritis and abnormal cell proliferation
11/25/2004	US20040236517 Selection of target sites for antisense attack of rna
11/25/2004	US20040236094 Using triplex complexes to generate preferential nucleotide sequences; in vitro DNA synthesis
11/25/2004	US20040236093 Using chimeric dendritic cells comprising viral epitopes to generate vaccines to prevent and treat viral diseases
11/25/2004	US20040236087 Moraxella(branhamella) catarrhalis antigens
11/25/2004	US20040236081 Immunoglobulin which binds interleukkin-1bconverting enzyme for use in diagnosis, treatment and prevention of autoimmune, neurodegenerative and cell proliferative disorders
11/25/2004	US20040236080 Particularly having antibody-dependent cell-mediated cytotoxicity activity or complement-dependent cytotoxicity activity, used for treating cancer
11/25/2004	US20040236073 A polypeptide with at least one amino acid replacement at position at 132, 134, 170, or 181; agonist of MET receptor
11/25/2004	US20040236072 Immunogenic polynucleotides, polypeptides, and antibodies used for detecting, immunizing against, and reducing beta-hemolytic streptococcal infection
11/25/2004	US20040235778 Methods for regulating hematopoiesis using CpG-oligonucleotides
11/25/2004	US20040235777 Enhancing immune response to cancer antigen comprising by administering a CpG (cytosine-phosphate diester-guanine) oligonucleotide; thrombopoiesis, anemia
11/25/2004	US20040235776 Use of inhibitors for the treatment of RTK-hyperfunction-induced disorders, particularly cancer
11/25/2004	US20040235775 Inhibition of hepatitis B virus (HBV) replication by RNA interference
11/25/2004	US20040235774 Immunostimulatory nucleic acids for the treatment of asthma and allergy
11/25/2004	US20040235772 DNA expression construct for the treatment of infections with leishmaniasis
11/25/2004	US20040235771 Means for eliciting an immune response and a method therefor
11/25/2004	US20040235769 Anti-tumor effects of prostage Carcinoma Tumor Antigen-1
11/25/2004	US20040235766 System for discovery of agents that block yersinia pestis and pseudomonas aeruginosa dna replication
11/25/2004	US20040235765 Administering as antitumor or anticarcinogenic agent; interference RNA

1 ... 2129 2130 2131 2132 2133 2134 2135 2136 2137 2138 2139 2140 2141 2142 2143 2144 2145 2146 2147 2148 2149 ... 4023